Skip to main content.

                                          

                                                            INNOVATIVE SOLUTIONS ADVANCING TREATMENT OF HUMAN DISEASES

Pipeline

TCT has developed an extensive portfolio of applications of its ground breaking technology platform and currently holds exclusive licenses for its fields.  We are currently developing applications through research programs targeting improvement of treatments for:

-Gaucher Disease and other lysosomal disorders                                                          -Low bone density conditions such as osteoporosis                                                      -Metastatic bone cancer and pain                                                                                      -Inflammatory disorders such as diabetes, IBD, carditis and asthma    

 

TCT has had early success in preclinical studies and are building out more extensive preclinical trials to demonstrate efficacy.